A Novel Peptide Ameliorates LPS-Induced Intestinal Inflammation and Mucosal Barrier Damage via Its Antioxidant and Antiendotoxin Effects

Intestinal inflammation is an inflammatory disease resulting from immune dysregulation in the gut. It can increase the risk of enteric cancer, which is a common malignancy globally. As a new class of anti-inflammatory agents, native peptides have potential for use in the treatment of several intesti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lulu, Wei, Xubiao, Zhang, Rijun, Si, Dayong, Petitte, James N., Ahmad, Baseer, Zhang, Manyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720008/
https://www.ncbi.nlm.nih.gov/pubmed/31443263
http://dx.doi.org/10.3390/ijms20163974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720008/
https://www.ncbi.nlm.nih.gov/pubmed/31443263
http://dx.doi.org/10.3390/ijms20163974

Ejemplares similares